Projects per year
Abstract
MicroRNA (miRNA) biogenesis is tightly regulated to maintain distinct miRNA expression patterns. Almost half of mammalian miRNAs are generated from miRNA clusters, but this process is not well understood. We show here that Serine-arginine rich splicing factor 3 (SRSF3) controls the processing of miR-17-92 cluster miRNAs in pluripotent and cancer cells. SRSF3 binding to multiple CNNC motifs downstream of Drosha cleavage sites within miR-17-92 is required for the efficient processing of the cluster. SRSF3 depletion specifically compromises the processing of two paralog miRNAs, miR-17 and miR-20a. In addition to SRSF3 binding to the CNNC sites, the SRSF3 RS-domain is essential for miR-17-92 processing. SHAPE-MaP probing demonstrates that SRSF3 binding disrupts local and distant base pairing, resulting in global changes in miR-17-92 RNA structure. Our data suggest a model where SRSF3 binding, and potentially its RS-domain interactions, may facilitate an RNA structure that promotes miR-17-92 processing. SRSF3-mediated increase in miR-17/20a levels inhibits the cell cycle inhibitor p21, promoting self-renewal in normal and cancer cells. The SRSF3-miR-17-92-p21 pathway operates in colorectal cancer, linking SRSF3-mediated pri-miRNA processing and cancer pathogenesis.
Original language | English |
---|---|
Article number | e56021 |
Number of pages | 14 |
Journal | EMBO Reports |
Volume | 24 |
Issue number | 7 |
DOIs | |
Publication status | Published - 5 Jul 2023 |
Keywords
- colorectal cancer
- miR-17-92
- pri-miRNA processing
- serine-arginine rich splicing factor 3
- SHAPE-MaP
Projects
- 4 Finished
-
Tapping the power of pluripotency: The role of HMGA1 protein in stem cell renewal and cell fate transitions.
Anko, M.-L. (Primary Chief Investigator (PCI)), Kaslin, J. (Chief Investigator (CI)), Davidovich, C. (Chief Investigator (CI)) & Ramialison, M. (Chief Investigator (CI))
1/01/18 → 31/12/20
Project: Research
-
Role of Snail proteins in mediating intestinal stem cell identity
Abud, H. (Primary Chief Investigator (PCI)), Hime, G. (Chief Investigator (CI)), Jones, L. (Chief Investigator (CI)) & McMurrick, P. (Chief Investigator (CI))
National Health and Medical Research Council (NHMRC) (Australia)
1/01/16 → 31/12/19
Project: Research
-
Alternative splicing- a regulatory mechanism determining self-renewal and pluripotency of ES and iPS cells
Anko, M.-L. (Primary Chief Investigator (PCI))
National Health and Medical Research Council (NHMRC) (Australia)
1/01/13 → 31/12/15
Project: Research
Equipment
-
FlowCore (FLOW)
Fryga, A. (Manager)
Faculty of Medicine Nursing and Health Sciences Research PlatformsFacility/equipment: Facility
-
MHTP Medical Genomics Facility
Wilson, T. (Manager)
Hudson Institute - Department of Molecular and Translational ScienceFacility/equipment: Facility
-
Monash Animal Research Platform (MARP)
Findlay, C. (Manager)
Faculty of Medicine Nursing and Health Sciences Research PlatformsFacility/equipment: Facility